Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch dextroamphetamine ...
Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
WASHINGTON — The Food and Drug Administration declared a nationwide shortage of Adderall, a drug used to treat ADHD, on Wednesday. The FDA cited that Teva, one of the major manufacturers of the drug, ...
In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback